Track topics on Twitter Track topics that are important to you
NEW YORK, June 4, 2015 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of Walgreen, Co. (Nasdaq:WBA) between March 25, 2014 and August 5, 2014.
You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Northern District of Illinois. If you purchased or otherwise acquired Walgreen, Co. ("Walgreen") securities between March 25, 2014 and August 5, 2014, your rights may be affected by this action. To get more information go to:
Walgreen and certain of its executives are charged with failing to disclose material information regarding Walgreen's business and prospects, including the purported benefits of Walgreen's strategic partnership with Alliance Boots GmbH during the Class Period.
If you suffered a loss in Walgreen you have until June 9, 2015 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Eduard Korsinsky, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.comNEXT ARTICLE
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...
Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...